ADVERTISEMENT
site_logo
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
  • Web Stories
  • edex_worksEDEXWORKS
ADVERTISEMENT
COVID-19

Published: 13th May 2020     

Microsoft offers grant to Shoolini University scientists for research on drugs to cure, prevent COVID-19

The team will perform much-needed screening of phytochemical constituents for anti-viral activity through interaction with COVID19 specific targets using molecular modeling studies

Edex Live
Edex Live
f_icon t_icon i_icon l_icon koo_icon whatsapp_icon email_icon Google News

Share Via Email

Shoolini

Image for representational purpose only |Pic: Google Images

A team of scientists from Himachal Pradesh-based Shoolini University has been offered a grant through Microsoft Artificial Intelligence for Health Programme to conduct research on finding drugs to cure and prevent COVID-19.

The project has been funded through High Performance Computing (HPC) Consortium, and the team led by Dr Gurjot Kaur, Associate Professor, School of Pharmaceutical Sciences, will have access to Microsoft Azure credits for the next six months to perform work using Microsoft licensed resources, that is, online platform and virtual machines.

The team will perform much-needed screening of phytochemical constituents for anti-viral activity through interaction with COVID-19 specific targets using molecular modeling studies.

Indian medicinal herbs have the same or similar phytoconstituents and do show great promise as anti-CoVID19 drugs. This project will directly influence the anti-viral drug development for COVID-19 and thus has a high impact.

According to Dr Gurjot Kaur, the current number of infected COVID-19 patients is on a rapid rise. While the government has implemented social distancing and a month-long lockdown, these are not good long-term solutions for the spreading pandemic.

A more viable idea would be to invest in the development of medicinal drugs both for prophylaxis as well as treatment of patients already infected with the virus.

Many existing anti-viral medications are being tried in the hope to slow or even cure the severely affected patients and thus, decrease the mortality rate. Unfortunately, none of the current medication strategies are optimum and vaccine development will take more than one year, she added.

Shoolini University Vice-Chancellor Prof PK Khosla, lauding the project undertaken by Dr Gurjot Kaur, said that the University would extend all its support for the project.

telegram
TAGS
COVID-19

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

newsletter_icon
Mailbox
edexlive@gmail.com
fb_icon
Facebook
twitter_icon
Twitter
insta_icon
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

The New Indian Express | The Morning Standard | Dinamani | Kannada Prabha | Samakalika Malayalam | Cinema Express | Indulgexpress | Events Xpress

Contact Us | About Us | Privacy Policy | Terms of Use | Advertise With Us

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take

Copyright - edexlive.com 2023. All rights reserved. Website Designed, Developed & Maintained by Express Network Private Ltd.